IPO registrations (S-1, F-1) · Registrants
ENDRA Life Sciences Inc.
- SEC CIK
- 1681682 · filings on EDGAR ↗
- Former names
- Endra Inc. (2016–2016)
- Registration
- Form S-1, first filed 2016-11-21, last 2025-07-25; 4 initial registrations, 17 amendments
- Outcome
- Final prospectus filed 2017-05-10; declared effective 2017-05-08; withdrawal requested 2026-05-26
- Industry (SIC)
- Electromedical & Electrotherapeutic Apparatus 3845
- Incorporated in
- DE
- Business address
- 3600 GREEN COURT, SUITE 350, Ann Arbor, MI 48105
- EIN
- 26-0579295
- Ticker
- NDRA (Nasdaq)
- EDGAR entity type
- operating
- Insiders and CEO pay
- ENDRA Life Sciences Inc. on the corporate pages
On this site
- Form 5500 plan sponsor: ENDRA INC EXACT (EIN (EXACT))
- Form D issuer: ENDRA Life Sciences Inc. EXACT (CIK (EXACT))
- SEC filer: ENDRA Life Sciences Inc. EXACT (CIK (EXACT))
Filings 37
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2016-11-21 | S-1 | S-1 (registration) | ENDRA Life Sciences Inc. | 0001654954-16-004197 ↗ |
| 2016-12-06 | S-1/A | S-1/A (amendment) | ENDRA Life Sciences Inc. | 0001654954-16-004599 ↗ |
| 2016-12-15 | S-1/A | S-1/A (amendment) | ENDRA Life Sciences Inc. | 0001654954-16-004918 ↗ |
| 2016-12-19 | S-1/A | S-1/A (amendment) | ENDRA Life Sciences Inc. | 0001654954-16-004963 ↗ |
| 2016-12-20 | S-1/A | S-1/A (amendment) | ENDRA Life Sciences Inc. | 0001654954-16-005006 ↗ |
| 2017-01-20 | S-1/A | S-1/A (amendment) | ENDRA Life Sciences Inc. | 0001654954-17-000390 ↗ |
| 2017-01-23 | S-1/A | S-1/A (amendment) | ENDRA Life Sciences Inc. | 0001654954-17-000432 ↗ |
| 2017-01-26 | S-1/A | S-1/A (amendment) | ENDRA Life Sciences Inc. | 0001654954-17-000494 ↗ |
| 2017-03-27 | S-1/A | S-1/A (amendment) | ENDRA Life Sciences Inc. | 0001654954-17-002461 ↗ |
| 2017-04-14 | S-1/A | S-1/A (amendment) | ENDRA Life Sciences Inc. | 0001654954-17-003323 ↗ |
| 2017-05-01 | S-1/A | S-1/A (amendment) | ENDRA Life Sciences Inc. | 0001654954-17-003822 ↗ |
| 2017-05-03 | S-1/A | S-1/A (amendment) | ENDRA Life Sciences Inc. | 0001654954-17-003973 ↗ |
| 2017-05-08 | S-1MEF | S-1MEF (added securities) | ENDRA Life Sciences Inc. | 0001654954-17-004195 ↗ |
| 2017-05-08 | EFFECT | EFFECT (declared effective) | ENDRA Life Sciences Inc. | 9999999995-17-001216 ↗ |
| 2017-05-10 | 424B1 | 424B1 (final prospectus) | ENDRA Life Sciences Inc. | 0001654954-17-004360 ↗ |
| 2018-09-04 | EFFECT | EFFECT (declared effective) | ENDRA Life Sciences Inc. | 9999999995-18-002268 ↗ |
| 2018-09-04 | EFFECT | EFFECT (declared effective) | ENDRA Life Sciences Inc. | 9999999995-18-002273 ↗ |
| 2019-02-08 | EFFECT | EFFECT (declared effective) | ENDRA Life Sciences Inc. | 9999999995-19-000133 ↗ |
| 2019-02-12 | EFFECT | EFFECT (declared effective) | ENDRA Life Sciences Inc. | 9999999995-19-000175 ↗ |
| 2019-09-13 | EFFECT | EFFECT (declared effective) | ENDRA Life Sciences Inc. | 9999999995-19-002092 ↗ |
| 2020-01-27 | EFFECT | EFFECT (declared effective) | ENDRA Life Sciences Inc. | 9999999995-20-000169 ↗ |
| 2021-05-03 | EFFECT | EFFECT (declared effective) | ENDRA Life Sciences Inc. | 9999999995-21-001744 ↗ |
| 2023-03-30 | S-1 | S-1 (registration) | ENDRA Life Sciences Inc. | 0001654954-23-003937 ↗ |
| 2023-04-18 | S-1/A | S-1/A (amendment) | ENDRA Life Sciences Inc. | 0001654954-23-004871 ↗ |
| 2023-04-19 | S-1/A | S-1/A (amendment) | ENDRA Life Sciences Inc. | 0001654954-23-004909 ↗ |
| 2023-04-27 | EFFECT | EFFECT (declared effective) | ENDRA Life Sciences Inc. | 9999999995-23-001075 ↗ |
| 2023-04-28 | S-1MEF | S-1MEF (added securities) | ENDRA Life Sciences Inc. | 0001654954-23-005338 ↗ |
| 2024-04-03 | EFFECT | EFFECT (declared effective) | ENDRA Life Sciences Inc. | 9999999995-24-000843 ↗ |
| 2024-04-19 | S-1 | S-1 (registration) | ENDRA Life Sciences Inc. | 0001654954-24-004823 ↗ |
| 2024-05-10 | S-1/A | S-1/A (amendment) | ENDRA Life Sciences Inc. | 0001654954-24-005980 ↗ |
| 2024-05-31 | S-1/A | S-1/A (amendment) | ENDRA Life Sciences Inc. | 0001654954-24-007150 ↗ |
| 2024-06-04 | EFFECT | EFFECT (declared effective) | ENDRA Life Sciences Inc. | 9999999995-24-001735 ↗ |
| 2025-07-09 | S-1 | S-1 (registration) | ENDRA Life Sciences Inc. | 0001654954-25-007870 ↗ |
| 2025-07-16 | S-1/A | S-1/A (amendment) | ENDRA Life Sciences Inc. | 0001654954-25-008117 ↗ |
| 2025-07-25 | S-1/A | S-1/A (amendment) | ENDRA Life Sciences Inc. | 0001654954-25-008477 ↗ |
| 2025-11-26 | 424B4 | 424B4 (final prospectus) | ENDRA Life Sciences Inc. | 0001213900-25-115097 ↗ |
| 2026-05-26 | RW | RW (withdrawal request) | ENDRA Life Sciences Inc. | 0001213900-26-061074 ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Harsh Michael | Director | 21 | 2017–2026 | ||
| Michelon Francois Roger | Director,Officer | Chief Executive Officer | 17 | 2017–2023 | |
| Thornton Michael Milos | Officer | Chief Technology Officer | 23 | 2017–2023 | |
| Wells David R. | Officer | Chief Financial Officer | 15 | 2017–2021 | |
| Tokman Alexander Y | Director; Director,Officer | Chief Executive Officer | 21 | 2017–2026 | |
| DIGIANDOMENICO ANTHONY | Director | 25 | 2017–2026 | ||
| Gambhir Sanjiv Sam | Director | 8 | 2017–2020 | ||
| Conrad Brett | TenPercentOwner | 2 | 2018 | ||
| Longboard Capital Advisors, LLC | TenPercentOwner | 2 | 2018 | ||
| Maloberti Renaud Bertrand | Officer | Chief Commercial Officer | 13 | 2019–2022 | |
| Basenese Lou | Director | 17 | 2020–2026 | ||
| Pestrikova Irina | Officer | Senior Director, Finance | 4 | 2021–2023 | |
| Jacroux Richard | Officer | Chief Financial Officer | 3 | 2024–2026 | |
| UBS Group AG | Other; TenPercentOwner | 4 | 2024 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2025-10-24 | ENDRA Life Sciences Inc. | Biotechnology | $14,402,880 | $14,402,880 | 6 | 1 |
| 2019-12-20 | ENDRA Life Sciences Inc. | Biotechnology | $8,555,000 | $8,555,000 | 151 | 1 |
| 2019-07-31 | ENDRA Life Sciences Inc. | Biotechnology | $2,805,000 | $2,805,000 | 86 | 1 |
| 2018-07-03 | ENDRA Life Sciences Inc. | Biotechnology | $1,097,000 | $1,077,000 | 18 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.